Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Some skin diseases and their treatments can negatively affect male fertility.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

The patient had complex urinary tract issues and ambiguous genitalia, with physical features suggesting a hormonal imbalance.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

A 73-year-old woman's unusual hair loss and growth led to the discovery of a rare condition causing too much testosterone, which improved after her ovaries were removed.

Finasteride doesn't affect hormone levels in normal men.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

The woman's symptoms and tests suggest her adrenal glands are producing too many male hormones.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Effective management of hyperandrogenism in young women requires accurate diagnosis and tailored treatment.